In addition to reducing the cost of GLP-1 drugs, this approach would enable doctors to individualize a patients dose to a level that enables them to gradually lose weight without uncomfortable side effects
GLP-1 Success A better GLP-1 journey starts here *Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise
The association between Semaglutide and lower dry eye incidence aligns with its documented anti-inflammatory properties, which may extend to ocular surface tissues 26
( "" , )
This has obvious benefits for those with Type 2 diabetes, but it can also help those who struggle with insulin resistance and weight maintenance
1 Introduction Diabetes mellitus (DM), characterized by chronic hyperglycemia, is escalating globally, contributing to heightened morbidity and mortality from diabetic complications (Yaribeygi et al., 2021)